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Infertility is a common distressing gynaecological 
problem with the male factor as a significant 
1
contributor . It is defined as the inability of a couple 
to achieve pregnancy within 12 months of regular 
unprotected sexual intercourse, with a worldwide 
prevalence of 10-15% among couples in the general 
2
population . In Africa, a prevalence of between 15 – 
3, 4, 5
40% is reported . It is classified as either female 
infertility, when the cause is in the female or male 
infertility, when the aetiology is in the male. Primary 
male infertility is the condition in which the man has 
not been able to fertilize a normal woman, while in 
secondary infertility, there was a previous 
fertilization of an ovum by the male spermatozoa.
Male factor infertility implies a lack of sufficient 
numbers of competent sperms resulting in failure to 
fertilize the normal ovum. The normality and 
competence of the semen is defined by the World 
Health Organization criteria and include the volume 
of the ejaculate, the concentration of spermatozoa, 
2
motility and morphological characteristics . There 
are concerns about the prognostic and clinical 
1
application of these criteria . A significant 
proportion of men with normal criteria are infertile 
6,7
because of defects in sperm function  while a 
significant number of men with abnormal have been 
6
shown to possess normal sperm function . In spite of 
the controversies about the reliability of these 
normal values, many researches are still based on 
them.
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ABSTRACT
Background: Infertility is a common gynecological problem. Most literatures are about female infertility with 
emphasis on infection sequelae and other factors such as anovulation. More recent studies reveal significant 
contribution from the males presenting as severe oligospermia and azoospermia. 
Objective: This literature reviews the genetic factors that contribute to male infertility, in the form of genic problem in 
the genes on the Y chromosome (primary) or sequelae of other genetic problems (secondary). They are discussed as 
pre- and post–spermatogenic. The common ones such as Y-chromosome microdeletions in the azoospermia factor 
(AZF) locus, Klinifelter syndrome 47XXY and Cystic fibrosis transmembrane conductance regulator (CFTR) gene 
mutations leading to congenital absence of the vas deferens (CAVD) are discussed. Other less common causes include 
Prader Willi syndrome, Kennedy disease, Katergener syndrome and Polycystic kidney disease.
Source: Medline search of local and non local articles, as well as standard text on human genetics were used for the 
review 
Conclusion: Genetic factors play an important role male infertility and knowledge about them forms the basis for the 
rational management of males with severe oligospermia and azoospermia especially in developing countries.
Keywords: Genetic, Male infertility, Clinical, Assisted Reproductive techniques, Semen 
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The abnormalities of seminalysis could occur singly 
or in combination
Hypospermia-  Semen volume less than 2mls
Oligospermia- Sperm concentration less than 20 x 
6
10 /ml
Azoospermia – Absence of sperm
Asthenozoospermia –Less than 50% with forward 
motility a,b
Teratospermia -- 15% normal forms
Teratozoosspermia – Abnormal morphology on 
microscopy
SCOPE OF GENETIC FACTORS IN 
MALE INFERTILITY
Male infertility is a multifactorial syndrome 
encompassing a wide variety of disorders. There is 
widespread variation in the prevalence of male 
infertility due to difficulty in getting accurate 
diagnosis. It is however agreed that the male factor 
1, 3is the single largest cause of infertility . It presents 
either as azoospermia or significant oligospermia. 
There is recently a better understanding of the role 
of genetics in male infertility, with about 10 -15% of 
reproductive failure in males due to an underlying 
1, 8
genetic factor . These occur as chromosomal 
1, 8
aberrations and single gene mutations . There is 
predominance of sex chromosomal abnormalities in 
1
azoospermia males .
Defective genes themselves can be inherited, 
produced by environmental assaults (such 
radiation exposure), or both. The mutations have 
a higher possibility of being transmitted to 
offspring when assisted reproductive methods 
involve direct injection of sperm into the female 
egg, because it avoids the natural selective 
mechanism. Also there could be abnormalities in 
the genes that regulate male fertility or in the 
genetic material of sperm itself. 
The genetic problems in male infertility could be 
classified as follows:
Primary Genetic Male Infertility – This is caused by 
an inherent genic abnormality especially of the 
genes on the Y chromosome that regulate or affect 
spermatogenesis. It is pre-spermatogenic problem. 
Secondary Genetic Male Infertility – This refers to 
infertility secondary to other genetic problems. 
Causes in this category may be pre-spermatogenic 
e.g Prader Willi syndrome, Klinefelter syndrome or 
post- spermatogenetic e.g Cystic fibrosis (CF).
Classification
ABNORMALITIES IN THE GENES / 
CHROMOSOMES THAT REGULATE OR 
AFFECT SPERMATOGENESIS (PRE 
SPERMATOGENESIS) 
Sperm cells are produced in the process of 
spermatogenesis. Spermatogenesis is in turn 
regulated by genes on the Y chromosome. The 
region involved in this regulation and fine tuning 
of spermatogenesis is located on the long arm 
(Yq11.21)
Structure of the Y chromosome
Y chromosome is made up of the short (p) and long 
arms (q) connected by a centriomere. The most 
distal part of the Y chromosome referred to as the 
pseudoautosomal regions occurs terminally on both 
arms and participates in the exchange of genetic 
materials with X chromosome during male meiosis. 
Next to the pseudoautosomal region is the 
genetically inert heterochromatic region that retains 
records of mutations occurring to the chromosome 
over the years. Sons inherit their father's portion 
during meiosis.
The Euchromatic region is the most vital region on 
the long arm necessary for spermatogenesis. 
Complete spermatogenesis is postulated to reside in 
the functionality of the locus referred to as 
Azoospermic factor (AZF) on the long arm of the 
9chromosome .  The AZF is divided into 3 different 
non overlapping sub regions (AZFa, AZFb, and 
AZFc), with each having important role in 
spermatogenesis. A fourth sub region, AZFd was 
10
recently identified . 
AZFa sub region contains the Ubiquitin-Specific 
peptidase 9 (USP9Y) and the DBY or Dead Box 3 
gene (DDX3Y). The USP9Y is involved in the 
production, fine tuning and improvement of 
efficiency of sperm cells, while the DDX3Y, Y RNA 
helicase is responsible for maturation and 
11spermatogenesis .The AZFb sub region has 5 
77
identifiable genes of which 3 are male fertility 
related. These are the RNA Binding Motif gene 
(RBM gene), which encodes proteins involved in 
spermatogenesis, Chromodomain Y (CDY) gene, a 
chromatin binding and XK related (XKRY) gene (X 
- linked Kell blood group), involved in 
12spermatogenesis . The genes in the AZFc sub 
region include the PTP-BL Related Y (PRY) gene, 
Basic Protein Y2 (BPY2) gene, Testis Transcript Y2 
(TTY2) gene and the Deleted in Azoospermia 
(DAZ) gene.
Y chromosome abnormality
Structural abnormality involving the Y 
chromosome is the most important cause of 
11
impaired spermatogenesis . The most frequent of 
these is the microdeletion and occurs in about 10-
10
20% of azoospermia or severe oligospermia . The 
microdeletions of AZF (a, b and c) locus occur 
during DNA replication. It has been mapped to 
deletion interval 5 – 7 in band q11.21- q11.23, 
although most deletions occur in deletion interval 5 
and 6. It may be singly or in combinations (AZFa, 
AZFb, AZFc, AZFb+c, AZFa+b+c). While the 
AZFa is rarely involved (2%), the AZFb is found to 
be recurrent deleted in infertile males and the AZFc 
is the most common complete deletion and known 
genetic cause of testicular dysfunction and male 
infertility. In some cases, Y microdeletion is 
compatible with formation of small numbers of 
normal spermatozoa. The affected males usually are 
perfectly healthy man apart from been infertile.  
Duplications can also involve the sub regions 
because the loci are prone to rearrangements 
13
causing azoospermia or oligozoospermia .  The 
AZFc region is one of the least stable regions in the 
human genome, consisting almost entirely of very 
long repeats and highly prone to rearrangement. 
Translocation involving the Y chromosome is 
another mechanism of male infertility. It is 
established that translocation between the autosome 
and Y chromosome producing a translocation 
chromosome Y causes pairing problems during 
male meiosis between the translocation Y and the 
normal X chromosome. The pairing abnormality 
leads to spermatogenic failure (degeneration of 
spermatocytes after pachytene stage) and is best 
observed at pachytene stage It is theorized that 
translocation causes disruption of gene responsible 
for replacement of histones involved in the 
14packaging of DNA into the sperm head .
Klinefelter Syndrome
Klinefelter syndrome is the commonest 
chromosomal abnormality associated with male 
14
hypogonadism and infertility . The incidence is 
between 1 in 600-1000 male live-births while it 
occurs in about 7-13% of azoospermic men. 
Available statistics about the prevalence especially 
in developing countries are extrapolated. In the 
USA, about 250,000 men are affected. The 
condition has no known racial predisposition.
Klinefelter syndrome is a numerical abnormality of 
the sex chromosome, in which an extra X is added to 
the normal XY due to meiotic nondisjunction. In the 
majority (90%) of affected males, the chromosomal 
constitution is 47 XXY, while mosaics 
(46XY/47XXY chromosome constitution) are 
found in about 10%. The features of this syndrome 
were first observed in 1942 and its association with 
abnormalities of spermatogenesis was confirmed by 
15
Klinefelter in 1959 . Affected males are normal in 
appearance before puberty. After puberty, the classic 
features include small firm testes, gynecomastia, 
azoospermia, disproportion in body size, abnormal 
social behaviour and below average IQ (depends on 
number of X chromosome). Infertility in Klinefelter 
syndrome results from the severe histological 
changes in the testicles hyalinization/destruction of 
the lining of the seminiferous tubules. Generally, 
affected men are infertile. Some can have healthy 
children, but also has increased chance to have a 
child with a sex chromosome abnormality.
ABNORMALITIES IN THE GENES OR 
CHROMOSOME THAT AFFECT THE 
TRANSPORT OR CONDUCTION CHANNEL 
O F  S P E R M  C E L L S  ( P O S T  
SPERMATOGENESIS)
Sperm cells after spermatogenesis are 
transported through the seminiferous tubules. 
Cystic Fibrosis 
Cystic Fibrosis is the most common autosomal 
recessive disease with highest prevalence in the 
14Caucasians . The prevalence is similar in both the 
United Kingdom and the United States of America, 
16being 0.737 and 0.797 per 10,000 respectively . It is 
generally speculated that the prevalence is low in 
African countries (except North Africa), probably 
due to under reporting or misdiagnosis of condition 
as chronic pulmonary infection and gastrointestinal 
infection, malnutrition, tuberculosis, or high infant 
17mortality rate . The predicted incidence is between 
17
1 in 784 and 1 in 13?924 births . 
The gene responsible for CF, also called cystic 
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fibrosis transmembrane regulator (CFTR) is located 
on chromosome 7. More than 150 identifiable 
mutations are reported, with the common ones being 
D 508 (70%), 5T, R117H, R75Q, G542X, N1303, 
W1282X, G551A, and R347H. They affect the 
processing of the gene products. Affected 
individuals have defects in ion transport across cell 
membranes that cause abnormal sticky viscous 
secretions from various body organs. CF is usually 
diagnosed in infancy and early childhood as a fatal 
condition. 
Above 95% of men with CF have fertility problem 
characterized by absence of portion or all of the 
reproductive ducts (including vas and seminal 
vesicles). When the 2 sides are involved, it is called 
congenital bilateral absence of the vas defence 
(CBAVD) while involvement of one side is referred 
to as congenital unilateral absence of the vas 
deferens (CUAVD). In both situation, there is 
trapping or obstruction to the passage of sperm and 
individual presents with azoospermia or 
oligospermia associated with low semen volume 
and acidic pH.  Spermatogenesis is intact. CBAVD 
may be associated with several diseases, including 
cystic fibrosis (CF). Detectable genetic mutation of 
one of the cystic fibrosis genes is found in 65 - 80% 
18of men with CBAVD . Among infertile males 
CBAVD is found in 2%. CUAVD affects 0.5-1% of 
the general population and rarely presents with 
infertility, because the individual have a normal side 
and is not azoospermic.
Other syndromes associated with male infertility. 
Prader Willi Syndrome (PWS)
The phenotype of PWS was initially described by 
19Langdon Down  and named after Prader Willi in 
201956 . It is as a rare condition that occurs 
sporadically. True population prevalence is difficult 
to determine. This condition is regarded as the first 
clinico-genetic disorder in humans caused by 
genomic imprinting. In about 75% of cases, the 
genomic imprinting is in the SNRPN gene located 
 
on the long arm of paternally derived chromosome 
15 (15q11-q13) during oogenesis and its concurrent 
deletion.  Consequently, the affected individual 
does not have a normal copy of this gene. In about 
20% of cases the condition arises from maternal 
uniparental disomy caused by chromosomal 
nondisjunction, while mutational error in the 
imprinting centre is responsible in about 2% of 
21individuals .
Infertility associated in Prader Willi syndrome is 
attributable to dysfunctional hypothalamic-
 
pituitary-gonadal axis, which manifests as retarded 
o r  i n c o m p l e t e  s e x u a l  d e v e l o p m e n t  
  12, 19(hypogonadotropic hypogonadism) . In some 
22cases, hypothalamic-pituitary-gonadal is normal . 
Puberty is usually delayed in children with Prader-
Willi syndrome. The histology of biopsies shows 
few germ cells, hyalinization and thickening of 
tubular basement membranes and atrophy of 
seminiferous tubules. The Leydig cells are largely 
23normal . It is as an autosomal dominant condition, 
with a 50% chance of transmission of the trait to the 
sons of affected father. 
Kennedy disease 
Kennedy disease v rris an inherited X linked 
disorder, characterized by late onset (about 30 
years), progressive neurone degeneration and 
muscular weakness. It was named after Williams 
Kennedy who first described it in 1968. This 
condition is also referred to as Spinobulbar 
muscular atrophy (SBMA). 
It is caused by mutation in a gene encoding a protein 
known as the androgen receptor (AR). Affected 
males have impaired AR that reduces the effect of 
male sex hormones. It is associated with reduced sex 
drive, infertility, impotence, and shrunken testicles. 
In some males, impaired sperm production follows 
testicular atrophy, while in a few cases, sexual 
function and fertility are normal. It is regarded as a 
rare genetic disease, with a higher prevalence 
reported in Western Finland.
Kartagener syndrome
The classical Kartagener syndrome describes the 
occurrence of si tus inversus,  sinusit is ,  
bronchiectasis and occasionally sterility in 
24,25
males . It is also called immotile cilia syndrome or 
primary ciliary dyskinesia because of its association 
with partial or total dysfunction of ciliary or 
flagellated cells. Most of the symptomatology is 
from the respiratory tract because of the 
predominance of ciliated cells in this organ. It is 
however, known that there are immotile 
spermatozoa with anoxemal structures found under 
EM studies in infertile males and this is suggested as 
the basis for including male sterility as an additional 
26component of this syndrome . 
The syndrome is an autosomal recessive disorder 
caused by a mutation in the DNAI1 gene, which 
produces a cellular protein required for normal 
function of the cilia and sperm motility. It occurs in 
25
1/6000 and 1/40000 of male infertility . Infertility 
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results from impaired sperm motility.
Polycystic Kidney Disease 
Autosomal dominant polycystic kidney disease is 
a systemic disorder with extrarenal organs such 
as the liver, pancreas and reproductive tract 
27
involved .
It is caused by a mutation affecting one out of three 
genes: PKD1 (on the 16th chromosome), PKD2 (on 
the 4th chromosome) and PKD3 (still unmapped) 
28 27, .This condition is associated with male infertility
28. 
It is theorized that imbalance between cell 
growth/proliferation inhibitors and stimulators 
leads to cyst formation that occupies the seminal 
vesicles, prostate and testes causing ejaculatory 
27,28 29obstruction and azoospermia . Other less 
frequently reported abnormality include 
axonemal 9 + 0 defect, severe congestion of the 
epididymis and marked pituitary dysfunction, 
28 9which is not reversed by dialysis .  Occasionally, 
there are structural abnormalities of the sperm such 
as asthenozoospermia and oligoteratospermia 
27related to abnormal function of polycystin . 
Clinical Considerations 
In clinical practice in many developing countries, 
the role of genetic factors in severe oligospermia 
and azoospermia has not been a major 
consideration. In the evaluation of male factor 
infertility due to genetic disorder, the following 
are important. Accurate diagnosis of the genetic 
factor is based on the history and physical 
examination. Counselling about all aspects of the 
condition including risk of transmission and 
finally management goals based on the diagnosis 
and therapeutic options available in the 
environment, are discussed with the couple.
A. DIAGNOSIS 
The appropriate management of genetic male 
infertility starts from making the diagnosis of the 
precise underlying genetic defect. It determines the 
prognosis, the treatment modality and ultimately the 
outcome of treatment.
HISTORY
This is the first step. CF is suggested by history of 
bulky stools ,  persis tent  coughing with 
accompanying phlegm, wheezing or shortness of 
breath. Abnormal social behavior in association 
with below average intelligence quotient may be the 
first symptom of Klinefelter syndrome. PWS is 
suggested by a previous history of genital 
hypoplasia, cryptochidism and delayed testicular 
descent even if there was a premature growth of 
29pubic and axillary hair . 
Pedigree analysis is recommended when the above 
features are found in other members of the family or 
recur in same family. It reveals the mode of 
inheritance. Vertical transmission is characteristic 
of autosomal dominant conditions, horizontal 
transmission of autosomal recessive disorders and 
absence of male to male transmission characteristic 
of X linked disorders. It should however be noted 
that in a number of cases, transmission is sporadic, 
with no delineable pattern of inheritance. For 
example, less than 10% of cases of Polycystic 
kidney disease are sporadic, and in the remaining 
90%, the disease has been inherited independently 
27from the mother or the father .
EXAMINATION
Physical examination follows history. It includes 
assessment of breast development, body stature, 
height and proportions of body parts. Klinefelter 
syndrome is characterized by tallness, asthenic 
stature with disproportionately long extremities, 
while short stature and robust built are more 
common in PWS. Assessment of the mental level of 
the individual is also important. Lower than average 
IQ may point to conditions such as PWS, while in 
combination with hyperactivity may suggest 
KIinefelter syndrome. Special emphasis should be 
given to the examination of the genitalia. Small firm 
testicles are found in Kennedy disease and 
Klinefelter syndrome. The pennis is small in CF and 
PWS. 
INVESTIGATIONS
The seminal fluid analysis is usually the first and 
perhaps the most important investigation carried out 
during infertility evaluation. It is also the most 
rewarding. Semen should be produced by 
masturbation and the parameters individually 
interpreted in relation to the history and examination 
findings.
Reduced volume with a low pH is characteristic of 
CBAVD. Azoospermia with near absence of 
fructose is associated with Polycystic disease of the 
kidney, while azoospermia alone is found in 
Klinefelter syndrome. Impaired motility is 
characteristic of Katargener syndrome. In all the 
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conditions, there may be severe oligospermia 
depending on the severity of the pathology.
Hormonal studies may reveal a pattern of 
hypogonadotrophic hypogonadism found in PWS. 
Ultrasound studies are vital investigative tool in 
male infertility. It could be by both 
transabdominal and transrectal approach. 
27Roser et. al (2008) , defined normal and 
abnormal parameters. Epididymal cysts are 
defined as well-defined anechoic areas with no 
internal echoes and with posterior acoustic 
enhancement. Seminal vesicle cysts were defined as 
discrete anechoic areas (simple cysts) or 
hypoechoic areas containing internal echoes 
(hypoechoic cysts) > 5 mm in diameter. Presence of 
isolated anechoic and isoechoic areas, is used to 
differentiate between seminal vesicle cysts and 
dilation of seminal vesicles. Prostate cysts were 
defined as discrete anechoic areas characteristically 
thin walled, well defined, homogeneous, and with 
posterior acoustic enhancement. Transrectal 
ultrasonography revealed severe congestion and 
extensive cystic changes in the seminal vesicles.
Karyoptyping is considered appropriate when there 
is a high index of suspicion for Klinefelter 
syndrome. In the absence of any other significant 
aetiology, all men with severe oligospermia and 
azoospermia, should be offered Y chromosome 
microdeletion analysis. Complete Cystic Fibrosis 
mutation studies should be done in azoospermia or 
oligospermia associated with acidic pH, because of 
the high chance of a mutation in at least one CF 
gene.
Testicular biopsy is rarely indicated in routine 
modern management of male infertility as most 
diagnosis can be concluded without it. It may 
however be used to further confirm diagnosis in 
some genetic conditions. 
COUNSELING
Counselling should be individualized using either 
directive or non directive counselling option. 
Caution must also be exercised. 
Y deletions are considered to be random/sporadic. It 
is expected that all sons inherit their fathers' Y 
chromosomes, and therefore all sons of a father with 
an AZF deletion would also inherit the deletion and 
are at high risk of presenting with infertility. 
However, brothers of affected individual usually 
have normal seminal fluid analysis and fertility. 
Klinefelter syndrome following meiotic non 
disjunction is a random event. The affected 
individuals can have healthy children, but also has 
increased chance to have a child with a sex 
chromosome abnormality. Counselling in CF, 
should emphasize the fact that the identification 
of one or even two cystic fibrosis (CF) 
mutations/variants does not imply that the 
individual is affected by the disease. When the wife 
is the carrier, each pregnancy/child has a CF risk of 
25% (95% with CF have fertility problem) and a 
carrier risk of 50%. If spouse is negative for the 
common mutation, her CF carrier risk is about 0.4% 
and the risk for this couple to have a child with CF 
genotype is no more than 0.2% (95% will present 
with infertility). In Kennedy disease it is important 
to inform the individual that it is an X linked 
recessive condition that is found in men, whose 
mother is a carrier of the mutation. Such males have 
a 50% risk of inheriting the disorder. In Kartagener 
syndrome, counselling dwells more on the difficulty 
in getting live semen for ICSI. 
MANAGEMENT
The management of male infertility due to 
genetic factors is influenced by the technology 
available for investigation and treatment. While 
the investigative procedures are much available 
in many advanced countries, they are scarce in 
most developing countries. 
The treatment options available include but not 
limited to the following: 
1.  Assisted reproductive techniques (ART)
2.  Adoption
The Assisted reproductive options used in male 
infertility are
In vitro fertilization and embryo transfer IVF-ET
Intracytoplasmic Sperm Injection (ICSI)
Micromanipulation techniques 
Microsurg ica l  Epid idymal  Sperm 
Aspiration
Percutaneous Epididymal Sperm Aspiration 
 
In obstructive conditions, such as CBAVD and 
Polycystic kidney disease, the sperm is entrapped 
and the recommended option is to retrieve semen by 
a suitable sperm aspiration technique such as PESA 
or MESA. The aspirated semen is genetically 
examined before fertilization through methods such 
as IVF-ET or ICSI. Complete spousal CF mutation 
analysis to define the risk of passing along CF or 
CBAVD to the offspring, is recommended when the 
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males has CBAVD and are scheduled for 
microsurgical epididymal sperm aspiration and 
subsequent ICSI. 
Males affected by Polycystic kidney disease and has 
normal seminalysis, should be offered the 
opportunity for sperm cryopreservation, while those 
with oligateratospermia and normal testicular 
biopsy could be considered for early microscopic 
epididymal sperm aspiration for in vitro 
fertilization.
CONCLUSION
Genetic factors are gradually becoming a crucial 
issue in the management of male infertility. It is 
important for clinicians to be aware of some of the 
common ones discussed in this review in order to 
optimize the care of affected couples.
.
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